Scott Wagner - 16 Mar 2024 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Signature
/s/ Gracye Cheng, Attorney-in-Fact for Scott Wagner
Issuer symbol
GDRX
Transactions as of
16 Mar 2024
Net transactions value
$0
Form type
4
Filing time
19 Mar 2024, 18:28:57 UTC
Previous filing
11 Dec 2023
Next filing
08 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GDRX Class A Common Stock 182,900 16 Mar 2024 By Wagner Family Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Restricted Stock Unit Award $0 +564,732 $0.000000 564,732 16 Mar 2024 Class A Common Stock 564,732 Direct F2, F3
transaction GDRX Stock Option (Right to Buy) Award $0 +908,739 $0.000000 908,739 16 Mar 2024 Class A Common Stock 908,739 $6.91 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held directly by the Wagner Family Trust (the "Trust"). The Reporting Person and his spouse serve as trustees of the Trust, and the Reporting Person, his spouse and other members of his immediate family are the sole beneficiaries of the Trust.
F2 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F3 The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates.
F4 The option will vest and become exercisable in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates.

Remarks:

Interim Chief Executive Officer